Expression of phosphorylated-mTOR during the development of prostate cancer. (Q38390821)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25043667%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

title

Expression of phosphorylated-mTOR during the development of prostate cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25043667%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

0 references

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25043667%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

James G Kench

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25043667%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

3

Susan M Henshall

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25043667%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

author name string

Sarah I M Sutherland

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25043667%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Ruth Pe Benito

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25043667%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

publication date

7 July 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25043667%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25043667%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

volume

74

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25043667%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25043667%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

page(s)

1231-1239

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25043667%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

cites work

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22840

Mechanisms of disease: high-grade prostatic intraepithelial neoplasia and other proposed preneoplastic lesions in the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22840

Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22840

Hypermethylation of the human glutathione S-transferase-pi gene (GSTP1) CpG island is present in a subset of proliferative inflammatory atrophy lesions but not in normal or hyperplastic epithelium of the prostate: a detailed study using laser-captur

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22840

Inflammation in prostate carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22840

Akt-regulated pathways in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22840

Prevalent mutations in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22840

Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22840

Prostate intraepithelial neoplasia induced by prostate restricted Akt activation: the MPAKT model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22840

mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22840

Activation of the mammalian target of rapamycin signalling pathway in prostate cancer and its association with patient clinicopathological characteristics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22840

mTOR-RAPTOR and 14-3-3σ immunohistochemical expression in high grade prostatic intraepithelial neoplasia and prostatic adenocarcinomas: a tissue microarray study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22840

Immunohistochemical examination of the mTORC1 pathway in high grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinomas (PCa): a tissue microarray study (TMA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22840

Membranous expression of secreted frizzled-related protein 4 predicts for good prognosis in localized prostate cancer and inhibits PC3 cellular proliferation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22840

Rapamycin inhibits proliferation of estrogen-receptor-positive breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22840

Integrative genomic profiling of human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22840

Inhibition of tumor growth progression by antiandrogens and mTOR inhibitor in a Pten-deficient mouse model of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22840

Phase II trial of RAD001 and bicalutamide for castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22840

Human prostate cancer precursors and pathobiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22840

Increased p53 immunoreactivity in proliferative inflammatory atrophy of prostate is related to focal acute inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22840

Decreased NKX3.1 protein expression in focal prostatic atrophy, prostatic intraepithelial neoplasia, and adenocarcinoma: association with gleason score and chromosome 8p deletion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22840

Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22840

Is PTEN loss associated with clinical outcome measures in human prostate cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22840

Risk of prostate cancer associated with a family history in an era of rapid increase in prostate cancer diagnosis (Australia)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22840

Genomic Deletion of PTEN Is Associated with Tumor Progression and Early PSA Recurrence in ERG Fusion-Positive and Fusion-Negative Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22840

Copy number alterations of c-MYC and PTEN are prognostic factors for relapse after prostate cancer radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22840

21 January 2018

Identifiers

DOI

10.1002/PROS.22840

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25043667%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

1 reference